Cancer News and Research

Latest Cancer News and Research

Prolonged hospitalization of advanced cancer patients linked to physical, psychological symptom burden

New research indicates that hospitalized patients with advanced cancer experience many physical and psychological symptoms, and that patients dealing with a higher burden of these symptoms have longer hospital stays and a greater risk for unplanned hospital readmissions.

23 Oct 2017

Systematic review finds lack of data on medical cannabis use in children and adolescents

A systematic review of published studies on the use of medical cannabis in children and adolescents finds a notable lack of studies and a minimal number of the randomized, controlled trials needed to confirm the effectiveness of a treatment.

23 Oct 2017

RAND researchers estimate health care savings over next decade from biosimilars

Introducing "biosimilar" versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut health care spending in the United States by $54 billion over the next decade, according to new analysis from the RAND Corporation.

23 Oct 2017

Research shows role of federal drinking water regulations in reducing arsenic exposure

New research conducted at Columbia University's Mailman School of Public Health found that exposure to arsenic in drinking water was significantly reduced among Americans using public water systems following the Environmental Protection Agency regulation on maximum levels of arsenic.

23 Oct 2017

Direct‐acting antiviral therapy linked to 71% reduction in liver cancer risk

A new study presented this week at The Liver Meeting - held by the American Association for the Study of Liver Diseases - found that eradication of the hepatitis C virus induced by direct‐acting antiviral medications is associated with a 71 percent reduction in the risk of liver cancer.

20 Oct 2017

Study examines risk of using liver organs from hepatitis C positive donors

Use of liver organs from selected hepatitis C positive donors should be considered due to modest risk of hepatitis C transmission and the availability of safe and effective direct‐acting antiviral therapies, according to research presented this week at The Liver Meeting - held by the American Association for the Study of Liver Diseases.

20 Oct 2017

Daily aspirin therapy linked to reduced risk of HBV‐related liver cancer

A new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found that daily aspirin therapy was significantly associated with a reduced risk in hepatitis B virus‐related liver cancer.

20 Oct 2017

HCV screening or diagnosis could lower non‐prescribed opioid use

Research presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – shows people in treatment for opioid substance abuse significantly lowered their non‐prescribed opioid use after testing positive for hepatitis C virus.

20 Oct 2017

Liver cirrhosis mortality found to be greater than that of five major cancers

A new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found that liver cirrhosis mortality is greater than that of five major cancers, implying the development of appropriate interventions to treat or prevent liver cirrhosis must be prioritized.

20 Oct 2017

Researchers use nanopore technique to detect biomarkers of disease

Adam Hall, Ph.D., isn't kidding when he says the research he does is on a very small scale. But he is understating things more than just a little.

20 Oct 2017

Pharmacological stimulation of nicotinic receptor could be strategy to treat lung inflammation

It has been amply proven that smoking can cause serious diseases such as emphysema and cancer. A new study, however, shows that pharmacological stimulation of a specific type of nicotinic receptor in cells of the immune system could be a strategy to treat inflammatory lung disease.

20 Oct 2017

Umass Amherst scientist receives grant to study pollutant effects on embryos in animal models

Environmental health scientist Alicia Timme-Laragy at the University of Massachusetts Amherst recently received a $1.9 million grant from the National Institute of Environmental Health Sciences to study the health effects of two environmental pollutants, perfluoro-octanesulfonic acid (PFOS) and its recent replacement chemical, perfluoro-butanesulfonic (PFBS).

20 Oct 2017

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

Following a successful clinical trial involving Dana-Farber Cancer Institute and Brigham and Women's Hospital, the first chimeric antigen receptor (CAR) T-cell therapy for adult cancers was approved by the Food and Drug Administration today.

20 Oct 2017

Gene circuit can be used to switch on inside cancer cells and stimulate immune attack, study suggests

A new study, conducted by researchers at MIT, suggests that a recently developed synthetic gene circuit can stimulate the immune system to kill cancer cells when it identifies indications of the cancer. The gene circuit will only stimulate a therapeutic response when it identifies two particular cancer markers.

20 Oct 2017

Findings suggest e-cigarettes may be just as bad as traditional cigarettes

E-cigarettes appear to trigger unique immune responses as well as the same ones that cigarettes trigger that can lead to lung disease, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

20 Oct 2017

Cancer News and Research

Latest Cancer News and Research

Prolonged hospitalization of advanced cancer patients linked to physical, psychological symptom burden

Systematic review finds lack of data on medical cannabis use in children and adolescents

RAND researchers estimate health care savings over next decade from biosimilars

Research shows role of federal drinking water regulations in reducing arsenic exposure

Direct‐acting antiviral therapy linked to 71% reduction in liver cancer risk

Study examines risk of using liver organs from hepatitis C positive donors

Daily aspirin therapy linked to reduced risk of HBV‐related liver cancer

HCV screening or diagnosis could lower non‐prescribed opioid use

Liver cirrhosis mortality found to be greater than that of five major cancers

Researchers use nanopore technique to detect biomarkers of disease

Pharmacological stimulation of nicotinic receptor could be strategy to treat lung inflammation

Umass Amherst scientist receives grant to study pollutant effects on embryos in animal models

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

Gene circuit can be used to switch on inside cancer cells and stimulate immune attack, study suggests

Findings suggest e-cigarettes may be just as bad as traditional cigarettes

Adipose-derived stem cell clinical trial focuses on non-healing leg wounds

Researchers discover new function in gene-regulatory protein

UGA researchers pinpoint factors that drive sharp rise in breast cancer genetic testing

Researchers reveal how certain nerves sustain prostate cancer growth

Amid for-profit surge, rural hospice has offered free care for 40 years

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in